Cloning and characterization of the NPCEDRG gene promoter.
NPCEDRG is a novel tumor suppressive gene that localizes to 3p21.3, a chromosomal region frequently associated with loss of heterozygosity (LOH) in a number of malignancies including nasopharyngeal carcinoma (NPC). Its transcriptional down-expression has been shown in the cell lines and primary tumor tissues of NPC. Reintroduction of NPCEDRG into CNE2, a cell line derived from NPC, was effective to induce cell differentiation, control cell growth, and regulate the cell cycle. Little is known about the transcriptional mechanisms controlling NPCEDRG gene expression. In this article, we describe the NPCEDRG gene structure and the transcriptional expression of NPCEDRG; we found that NPCEDRG was expressed weakly in most of NPC cell lines. Using 5' rapid amplification of complementary DNA ends (5'-RACEs), we found that the NPCEDRG gene has several transcription start sites (TSSs) due to the existence of alternatively spliced variants, and the specific TSS of NPCEDRG was located -25 nucleotides upstream of the translation start site. We amend that Human NPCEDRG CDS containing 516 bp but not the 510 bp reported previously. To characterize the NPCEDRG promoter, transient luciferase and/or EGFP reporter assay were carried out with the constructs including various lengths of the 5' flanking region of the NPCEDRG gene. The results demonstrated that the basal promoter is located at the region from -215 to -8 nucleotides, and the optimal promoter is located at the region from -625 to -8 nucleotides upstream of the translation start site. In silico analysis suggested that the promoter region contained potential binding sites for SP1, c-Myb, AREB6, Nkx2-5, and so on. These results provide important clues to elucidate the regulation of NPCEDRG gene expression and function. Further studies are apparently required for the identification of the transcription factors, essential for NPCEDRG expression, which would lead to better understanding of the molecular mechanism of NPCEDRG expression in nasopharyngeal epithelial cells.
Hou
Defu
D
Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, Xiangya Hospital, Central South University, 87# Xiangya Road, Changsha, 410008, Hunan, China.
Guan
Yongjun
Y
Liu
Jianping
J
Xiao
Zhefeng
Z
Ouyang
Yongmei
Y
Yu
Yanhui
Y
Chen
Zhuchu
Z
D001483:Base Sequence; D002453:Cell Cycle; D002454:Cell Differentiation; D045744:Cell Line, Tumor; D002893:Chromosomes, Human, Pair 3; D017931:DNA Primers; D016147:Genes, Tumor Suppressor; D006801:Humans; D019656:Loss of Heterozygosity; D009303:Nasopharyngeal Neoplasms / Q000235:genetics; D011401:Promoter Regions, Genetic; D020133:Reverse Transcriptase Polymerase Chain Reaction; D025521:Tumor Suppressor Proteins / Q000235:genetics*
D017931:DNA Primers; C557244:NPCEDRG protein, human; D025521:Tumor Suppressor Proteins
Mol Cell Biol. 2000 May;20(10):3608-15
10779350
PLoS One. 2009;4(4):e5103
19337366
Neoplasia. 2005 Jan;7(1):67-74
15720818
Methods Mol Biol. 2000;132:337-49
10547845
Nucleic Acids Res. 2008 May;36(9):2906-16
18385157
Trends Genet. 2000 Jun;16(6):276-7
10827456
Cancer Res. 2004 Mar 15;64(6):1972-4
15026332
Eur J Biochem. 2002 Nov;269(21):5240-5
12392556
Genet Med. 2006 Mar;8(3):156-60
16540749
Curr Protoc Bioinformatics. 2008 Mar;Chapter 2:Unit 2.6
18428685
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19932-7
19060205
Mol Cell Biol. 2005 Dec;25(23):10379-90
16287852
Int J Cancer. 1990 Jun 15;45(6):1033-9
2351484
N Engl J Med. 2001 Dec 27;345(26):1877-82
11756578
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3042-7
9501212
Oncol Res. 2006;16(6):261-72
17476971
Ai Zheng. 2003 Jan;22(1):1-5
12561426
Cancer Res. 1997 Aug 1;57(15):3154-8
9242443
Cancer Res. 1996 Apr 1;56(7):1487-92
8603390
Int J Cancer. 2006 Dec 15;119(12):2821-6
16929489
Nucleic Acids Res. 2006 Mar 15;34(5):1492-500
16540593
Nature. 1990 Aug 2;346(6283):470-1
2377207
Nucleic Acids Res. 2000 May 15;28(10):2091-8
10773077
Gene. 2000 Jan 4;241(1):3-17
10607893
Genes Dev. 2003 Jun 1;17(11):1309-20
12782648
Cancer Res. 2003 Jan 15;63(2):404-12
12543795
Cancer Res. 1992 Jun 1;52(11):3048-51
1317256
Oncogene. 2006 Jan 12;25(2):310-6
16116475
Mol Cell Biochem. 2007 Apr;298(1-2):93-100
17146594
Cancer Genet Cytogenet. 2006 Jul 15;168(2):105-8
16843099